Financial newsfor AI agents.

Market-moving stories, structured for trading automations. Plug into Claude Desktop, Cursor, or your own agent in minutes.

10,000+

Crawled and deduplicated across the open web. The strongest candidates get a full AI pass with a 1–10 relevance score and per-ticker analysis.

6,900+

Distinct publisher domains scanned in the last 30 days.

<1 in 5

Only the best clear the relevance floor with a verified ticker. The rest is filtered out.

~6 min

Median from EDGAR publication to an enriched, ticker-tagged row, covering insider trades (Form 4), corporate actions (8-K) and foreign issuers' earnings releases (6-K).

All of it can come to you. News alerts land in Telegram, email, or a webhook the moment a story clears your filters, and the tickers, categories, and relevance threshold are yours to set.

Set up alerts

Built for AI agents and trading bots.

Shell acquires 30% non‑operated interest in Equinor’s Bay du Nord offshore oil project

Equinor announced that Shell will purchase a 30% non‑operated stake in the Bay du Nord development off Newfoundland and Labrador, while Equinor keeps a 70% share and remains the operator. The transaction was disclosed on 9 Oct 2026 and is subject to regulatory clearance. The partnership is intended to move the project toward a final investment decision expected in early 2027, with first oil targeted for 2031.

$EQNR$SHELRead the story

Vaxcyte prices and closes $1 billion‑plus equity and convertible‑note offerings

Vaxcyte announced the pricing of concurrent public offerings of 7.8 million shares at $64 each, pre‑funded warrants and $500 million of 1.50% convertible senior notes due 2032. The offerings closed on October 9, 2026, with underwriters exercising their over‑allotment options, raising total gross proceeds to about $1.15 billion. Net proceeds will be used to fund clinical development and manufacturing of the VAX‑31 pneumococcal vaccine program and other pipeline activities.

Viatris to acquire Pacira BioSciences in a $1.65 billion cash deal

Viatris announced a definitive agreement to purchase all outstanding shares of Pacira BioSciences for $36.50 in cash per share, valuing the transaction at $1.65 billion. The acquisition adds the non‑opioid pain products EXPAREL and ZILRETTA to Viatris’ portfolio and is expected to close by the end of 2026, subject to customary conditions. Viatris said the purchase will be funded mainly with its excess cash and a portion of short‑term borrowings, and it expects the deal to be immediately accretive to its guidance. Pacira’s board recommends shareholders tender their shares, after which Pacira will become a wholly‑owned Viatris subsidiary and cease trading on Nasdaq.

CD&R and McKesson agree to acquire Option Care Health

On October 6, 2026, Clayton, Dubilier & Rice and McKesson agreed to acquire Option Care Health for $32.05 per share, implying approximately $5.8 billion in enterprise value. CD&R will take approximately 51% ownership, while McKesson will invest approximately $1.4 billion for approximately 49%. Completion is targeted for the first half of calendar year 2027, conditional on stockholder approval and required regulatory clearances.

Samsung Electronics posts record Q3 operating profit above 100 trillion won

Samsung Electronics reported a preliminary third‑quarter operating profit of 107.4 trillion won, the first time the South Korean giant has topped the 100‑trillion‑won mark. Revenue for the quarter was 195 trillion won, up 127% year‑over‑year, and the operating margin rose to 55.1%. The surge was driven by AI‑related memory chip demand, especially high‑bandwidth memory, while its device‑experience businesses continued to lose money.

$AZOLow

AUTOZONE INC (AZO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

AUTOZONE INC (AZO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 6, 2026, Claire R. McDonough communicated to the Board of Directors (the “Board”) of AutoZone, Inc. (the “Compa

$GTEMed

GRAN TIERRA ENERGY INC. (GTE): Submission of Matters to a Vote of Security Holders

GRAN TIERRA ENERGY INC. (GTE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Exhibit 99.1 Gran Tierra Energy Inc. Stockholders Approve Sale of Colombian and Ecuadorian Businesses CALGARY, Alberta - October 9, 2026 (GLOBE NEWSWIRE) - Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) today announced that its stoc

$IARTMedAI 8/10

Integra Announces Pricing of Senior Secured Notes

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Integra Announces Pricing of Senior Secured Notes PRINCETON, N.J., October 9, 2026 – Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033

The same feed, as an API.

The same scored news feed that powers AlphAI is available as a REST API, and as an MCP server for Claude Desktop, Cursor, and any other agent host. Articles arrive enriched and linked to tickers in real time.

  • Real-time + historical news
  • Per-ticker filters and search
  • Relevance-scored 1–10
  • Free tier + paid scale

Dropping it into an existing stack? The Python and n8n quick starts are copy-paste.

curl https://api.alphai.io/api/news/ \
  -H "Authorization: Bearer ${ALPHAI_API_KEY}" \
  -G -d "symbol=NVDA"

# → {
#   "results": [{
#     "original": {
#       "title": "Nvidia export curbs tighten...",
#       "summary": "The White House is expected to...",
#       "time_published": "2026-04-18T14:32:00Z"
#     },
#     "enrichment": {
#       "category": "macro",
#       "tickers": ["NVDA"],
#       "relevance_score": 9
#     }
#   }, ...],
#   "next_cursor": "MjAyNi0wNC0xOFQxNDozMjowMHw0Mg=="
# }

Three plans. One feed.

Free reads the feed and probes the APIs. Paid plans drop the ads and scale up the rate.

Free

$0forever
  • Unlimited articles on the website
  • REST + MCP: 20 / min · 100 / day each, 1 API key
  • Sponsored placements visible
Start for free

Basic

$2.99$7.99/month
  • No ads, unlimited watchlist
  • Daily digest of ticker alerts
  • REST API: 60 / min · 10,000 / day, 1 key
  • MCP server: 60 / min · 10,000 / day
Get started

Pro

$9.99$24.99/month
  • Everything in Basic
  • REST API: 150 / min · 100,000 / day, 5 keys
  • MCP server: 150 / min · 100,000 / day + bulk
Get started

Subscribe now and keep this rate for as long as you stay subscribed. We will not raise it for you.

Don’t want to watch the feed? Follow a ticker and we’ll deliver a daily digest of everything that clears your relevance bar, so you don’t have to check back.

Set up alerts